BioInnovation Institute (BII) is launching AI Lab, a new innovation platform designed to support the commercialisation of artificial intelligence research and accelerate the development of early-stage AI startups in Denmark. The initiative is backed by € 7 million (DKK 60 million) in funding from the Danish Industry Foundation and aims to strengthen collaboration between startups, researchers and industrial companies while helping bring AI-based technologies to market more quickly.
AI Lab will be operated by BII, which, since 2018, has supported more than 140 startups across life sciences, quantum technology and biosolutions with funding, infrastructure and commercialisation support. Through the AI Lab, BII will expand its activities into artificial intelligence, focusing on helping startups develop scalable AI solutions and attract external investment.
The programme will provide selected startups with non-dilutive financial support, access to datasets from Danish companies and institutions, computing infrastructure, technical guidance and connections to potential customers through BII’s industry network. AI Lab will also include an AI-focused accelerator programme designed to help startups become investment-ready and launch pilot projects more quickly.
